Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Track AZN with free AI briefings, catalyst countdowns, and dilution alerts.

AZN · ASTRAZENECA PLC

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$5B Cash on Hand

CF+ Cash Runway

Follow AZN by email Get an email when AZN pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about AZN, unsubscribe in one click. Privacy

🧪 Trial & FDA Catalysts

Oct 2026 · Phase 4 · Active Trial · Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics
Registry primary completion date, not a results date
Oct 2026 · Phase 2 · Active Trial · This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obe
Registry primary completion date, not a results date
Oct 2026 · Phase 1 · Recruiting · Investigating the Effect of Itraconazole on the Pharmacokinetics of AZD4144 in Healthy Par
Registry primary completion date, not a results date
Oct 2026 · Phase 4 · Active Trial · Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian Patients
Registry primary completion date, not a results date
Nov 2026 · Phase 2 · Recruiting · AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Registry primary completion date, not a results date
Nov 2026 · Phase 1 · Recruiting · A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulati
Registry primary completion date, not a results date

📊 Drug Pipeline

Drug	Indication	Most advanced trial	Status
Durvalumab FDA approved May 2017 · Imfinzi	Breast Cancer	Phase 3 · NCT06103864	Recruiting
Olaparib FDA approved Dec 2014 · Lynparza (discontinued)	Fallopian Tube Clear Cell Adenocarcinoma	Phase 3 · NCT02446600	Active not recruiting
Tremelimumab FDA approved Oct 2022 · Imjudo	Non Small Cell Lung Cancer	Phase 3 · NCT04585490	Recruiting
Anifrolumab FDA approved Jul 2021 · Saphnelo	Systemic Lupus Erythematosus	Phase 3 · NCT05835310	Recruiting
Camizestrant (AZD9833) FDA approved Sep 2026 · Etcamah	ER-Positive HER2-Negative Breast Cancer	Phase 3 · NCT04711252	Active not recruiting
Benralizumab FDA approved Nov 2017 · Fasenra	Asthma	Phase 3 · NCT05692180	Active not recruiting
Acalabrutinib FDA approved Oct 2017 · Calquence	Non Hodgkin Lymphoma	Phase 1/2 · NCT02180711	Active not recruiting
Cediranib Maleate	Fallopian Tube Clear Cell Adenocarcinoma	Phase 3 · NCT02446600	Active not recruiting
Elecoglipron	Heart Failure With Preserved Ejection Fraction (HF	Phase 3 · NCT07761117	Recruiting
Eribulin	Breast Cancer	Phase 3 · NCT03734029	Completed
Rilvegostomig	Carcinoma, Non-Small Cell Lung	Phase 3 · NCT06868277	Recruiting
Datopotamab Deruxtecan	Breast Cancer	Phase 3 · NCT06103864	Recruiting
Gonadotropin-releasing Hormone Analog	ER-Positive HER2-Negative Breast Cancer	Phase 3 · NCT04711252	Active not recruiting
Nab-paclitaxel	Breast Cancer	Phase 3 · NCT06103864	Recruiting
Pegylated Liposomal Doxorubicin Hydrochl	Fallopian Tube Clear Cell Adenocarcinoma	Phase 3 · NCT02446600	Active not recruiting
Volrustomig	Locally Advanced Head and Neck Squamous Cell Carci	Phase 3 · NCT06129864	Recruiting

Also used in these trials (approved or third-party drugs, not AZN's own candidates): Dexamethasone Mouthwash, Gemcitabine Hydrochloride, Carboplatin, Carfilzomib, Cisplatin, Daratumumab, Dexamethasone, Pomalidomide, Pemetrexed Disodium, Pembrolizumab, Paclitaxel, Palbociclib.

Source: ClinicalTrials.gov trials sponsored by the company, one row per candidate at its most advanced registered trial. FDA approvals: Drugs@FDA. Wrong or missing drug? Report it

💰 Cash Runway & Dilution Risk

AZN holds $5B in cash and short-term investments and its operations are currently cash-flow neutral or positive.

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when AZN files for a raise →

Get the full AZN picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for AZN and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z